Advanced search
Publication Cover
Renal Failure Volume 29, 2007 - Issue 7
Submit an article Journal homepage
1,045
Views
17
CrossRef citations to date
0
Altmetric
Case Report

Acute Renal Failure Secondary to Fenofibrate Monotherapy-Induced Rhabdomyolysis

M. Tahmaz Haseki Research and Training Hospital, Department of Internal Medicine and Nephrology, Istanbul, Turkey
,
B. Kumbasar Haseki Research and Training Hospital, Department of Internal Medicine and Nephrology, Istanbul, Turkey
,
K. Ergen Haseki Research and Training Hospital, Department of Internal Medicine and Nephrology, Istanbul, Turkey
,
U. Ure Haseki Research and Training Hospital, Department of Internal Medicine and Nephrology, Istanbul, Turkey
,
G. Karatemiz Haseki Research and Training Hospital, Department of Internal Medicine and Nephrology, Istanbul, Turkey
&
R. Kazancioglu Haseki Research and Training Hospital, Department of Internal Medicine and Nephrology, Istanbul, TurkeyCorrespondence[email protected]
Pages 927-930 | Published online: 07 Jul 2009

REFERENCES

  • Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000; 11: 1553–1561
  • Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 1988; 148: 1553–1557
  • Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998; 98: 2088–2093
  • Knoop RH. Drug treatment of lipid disorders. N Eng J Med. 1999; 341: 498–511
  • Adkins JC, Faulds D. Micronised fenofibrate: A review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidemia. Drugs. 1997; 54: 615–633
  • Hodel C. Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett. 2002; 128: 159–168
  • Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996; 19: 311–326
  • Thomas MA, Ibels LS. Rhabdomyolysis and acute renal failure. Aust NZJ Med. 1985; 15: 623–630
  • Dovignon J. Fibrates: A review of important issues and recent findings. Can J Cardiol. 1994; 10(S)61B–71B
  • Miller DB, Spence JD. Clinical pharmacokinetics of fibric acid derivatives (fibrates). Clin Pharmocokinet. 1998; 14: 156–162
  • Graham DJ, Staff JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid–lowering drugs. JAMA. 2004; 292: 2585–2590
  • Broeders N, Knoop C, Antoine M, Abramowicz D. Fibrate induced-renal dysfunction: Is gemfibrozil the only non-nephrotic agent?. Transplantation. 1999; 67S: S170
  • Shepherd J. Fibrates and statins in the treatment of hyperlipidemia: An appraisal of their efficacy and safety. Eur Heart J. 1995; 16: 5–13
  • Curry SC, Chong D, Connor D. Drug and toxin-induced rhabdomyolysis. Ann Emerg Med. 1989; 18: 1068–1084
  • Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine. 1982; 61: 141–153
  • Atef MR, Nadjatfi I, Boroumand B, Rastegar A. Acute renal failure in earthquake victims in Iran: Epidemiology and management. Q J Med. 1994; 87: 35–40
  • Barker JB, Goodenough RR, Falko MJ. Fenofibrate monotherapy induced rhabdomyolysis. Diabetes Care. 2003; 26: 2482–2483
  • Jones PH, Davidson MH. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am J Cardiol. 2005; 95: 120–122
  • Gorriz JL, Sancho A, Lopez-Martin JM, et al. Rhabdomyolysis and acute renal failure associated with gemfibrozil monotherapy. Nephron. 1996; 74: 437–438
  • Clouatre Y, Leblanc M, Ouimet D, Pichette V. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism. Nephrol Dial Transplant. 1999; 14: 1047–1048

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.